Cervical Approach to Substernal Goiter: Do we Need Sternotomy? Cerrahpaşa Experience

Purpose: The purpose of this study was to evaluate the clinical and surgical differences between substernal goiter and non substernal goiter according to institutional experience. Material and Method: Twenty-nine patients with substernal goiter and 62 randomly chosen non substernal goiter patients from January 2009 to October 2012 were compared retrospectively according to their pre-operative and post-operative data. Cervical approached total thyroidectomy was applied to patients with substernal goiter. Results: Thirteen of twenty-nine substernal goiter patients were male (44.8%) and 16 were female (55.2%). Body mass index, age, gender in both groups were compared and found to be similar. No post-operative complication was observed. Pathology results revealed malignancy in 24.1% of patients. Discussion: Patients with substernal goiter can be safely treated through the cervical approach with low complication rates in expert hands. Turk Jem 2013; 17: 116-2

Cervical Approach to Substernal Goiter: Do we Need Sternotomy? Cerrahpaşa Experience

Purpose: The purpose of this study was to evaluate the clinical and surgical differences between substernal goiter and non substernal goiter according to institutional experience.\ud Material and Method: Twenty-nine patients with substernal goiter and 62 randomly chosen non substernal goiter patients from January 2009 to October 2012 were compared retrospectively according to their pre-operative and post-operative data. Cervical approached total thyroidectomy was applied to patients with substernal goiter.\ud Results: Thirteen of twenty-nine substernal goiter patients were male (44.8%) and 16 were female (55.2%). Body mass index, age, gender in both groups were compared and found to be similar. No post-operative complication was observed. Pathology results revealed malignancy in 24.1% of patients.\ud Discussion: Patients with substernal goiter can be safely treated through the cervical approach with low complication rates in expert hands. Turk Jem 2013; 17: 116-2

Efficacy of PET-CT in the prediction of metastatic adrenal masses that are detected on follow-up of the patients with prior nonadrenal malignancy: A nationwide multicenter case-control study

Metastasis is the second most common type of adrenal gland mass. In patients undergoing follow-up for nonadrenal malignancy, adrenalectomy is performed when metastasis to adrenal gland is suspected on the basis of positron emission tomography-computed tomography (PET-CT) imaging. This study investigated the efficacy of PET-CT in the discrimination of metastatic lesions from nonmetastatic lesions in the adrenal glands. In this multicentric study, data was collected from enrolled centers. Forty-one patients who underwent surgery for suspected adrenal metastases were evaluated retrospectively. The following data types were collected: demographic, primary tumor, maximum standardized uptake value of adrenal mass (a-SUVx) and detectability in computed tomography and/or magnetic resonance imaging, and specimen size and histopathology. Six patients were excluded due to unavailability of PET-CT reports and 4 for being primary adrenal malignancy. The rest were divided into 2 groups (metastatic: n = 17, 55% and nonmetastatic: n = 14, 45%) according to histopathology reports. There was no statistical difference between the analyzed values, except the a-SUVx (P .05). It was found that PET-CT was able to discriminate metastatic lesions from primary benign lesions (P = .022). PET-CT can discriminate primary benign lesions and metastatic lesions by cutoff 5.5 value for a-SUVx